search

Total posts by Eli Lilly and Co.: 9

presentation · 5 years ago
Making Workflows Work: Enterprise deployment of KNIME at Lilly
by James Lumley (Eli Lilly and Co.)
poster · 5 years ago
Open Innovation Drug Discovery Program
(Eli Lilly and Co.)
publication · 6 years ago
Distributed Drug Discovery, Part 3: Using D3 Methodology to Synthesize Analogs of an Anti-Melanoma Compound
by William L. Scott, Martin J. O'Donnell, Christopher O. Audu, Lawrence A. Goodwin, Jeffrey L. Dage, Laura K. Platt, Jacek G. Martynow, Andrew T. Strong, Judith G. Smith, Kirk Wickizer, Eric M. Woerly (Eli Lilly and Co., Indiana University-Purdue University)
presentation · 6 years ago
The Lilly Open Innovation Drug Discovery Program
by Daniel Robertson (Eli Lilly and Co.)
publication · 7 years ago
Kinase Inhibitor Data Modeling and de Novo Inhibitor Design with Fragment Approaches
by Ian A. Watson, Michal Vieth, Jon Erickson, Jibo Wang, Yue Webster, Mary Mader, Richard Higgs (Eli Lilly and Co.)
publication · 7 years ago
3D QSAR Methods: Phase and Catalyst Compared
by David A. Evans, Thompson N. Doman, David A. Thorner, Michael J. Bodkin (Eli Lilly and Co.)
publication · 7 years ago
A simple and efficient approach to reversed-phase HPLC method screening
by Kallol M. Biswas, Bryan C. Castle, Bernard A. Olsen, Donald S. Risley, Michael J. Skibic, Paul B. Wright (Eli Lilly and Co.)
presentation · 9 years ago
SPrime: Computational Chemistry Application and Framework for Drug Discovery
by Hongzhou Zhang (Eli Lilly and Co.)
presentation · 9 years ago
A knowledge-based approach for reaction generation: development, validation and applications
by Dimitar Hristozov (Eli Lilly and Co.)